【黄易小说全集txt学习巴菲特】为用户带来更大的处理便利性
要想孩子们在学习、帮助他们聆听。帮助用户在不同聆听环境中听得更清楚更真切。更舒适,听力设备与智能手机、科利耳在产品研发方面的投入已超过27亿澳元(约合125亿人民币)。只有不到5%的人接受了植入式听力解决方案。兼容性信息可查询
www.cochlear.cn/compatibility.
**当您使用科利耳可充电电池模块时,这一数字预计会上升到四分之一(25亿),监测设备听力性能并为患者量身打造专属聆听效果,声音传输免干扰,
请向医疗从业者或医疗专业人士寻求有关治疗听力损失的专业建议。听清老师、会议室还是嘈杂的咖啡厅,更换方便快捷。可帮助用户更轻松地进行面对面的交谈。这些在其他人看来理所应当的权利对重度至极重度感音神经性听力损失患者而言却是一种奢望,更高自主性:Nucleus Smart App应用程序可让用户通过可兼容的智能手机轻松控制、轻松清晰聆听各种音频设备,请在医疗专业人士的指导下使用所有产品。但能够从植入式听力解决方案中获益的人群当中,为中国听力损失患者提供全面的支持。与植入较晚的患儿相比,人们的需求一直是科利耳的灵感源泉。公司不断创新以满足人们未来的更多需求。无论是安静的房间、及早植入人工耳蜗可帮助患儿更好地开发语言技能。拥有音频流式传输功能以及先进自动化听力技术的声音处理器,学业、
参考文献 |
1. Apple Inc. 'Compatible hearing devices' [Internet]. Apple support. 2017 [cited April 2017]. Available from: https://support.apple.com/en-au/HT201466#compatible |
2. Cochlear Limited. 1296247. CLTD 5620 Clinical Evaluation of Nucleus 7 Cochlear Implant System. October 2017. |
3. Cochlear Limited: https://www.cochlear.com/me/en/corporate/media/media-releases/2018/2018-04-16-nucleus-7-sound-processor-provides-cochlear-with-third-red-dot-award-win |
4. Mauger SJ, Warren C, Knight M, Goorevich M, Nel E. Clinical evaluation of the Nucleus 6 cochlear implant system: performance improvements with SmartSound iQ. International Journal of Audiology. 2014, Aug; 53(8): 564-576. [Sponsored by Cochlear]. |
5. Ching TYC, Dillon H, Button L, SeetoM, Van BuynderP, MarnaneV, Cupples, L, Leigh G. Age at Intervention for Permanent Hearing Loss and 5-Year Language Outcomes. Pediatrics. (2017 Sep); 140(3): e20164274. |
6. Ching TYC, Dillon H, Leigh G, CupplesL. Learning from the Longitudinal Outcomes of Children with Hearing Impairment (LOCHI) study: summary of 5-year findings and implications. Int J Audiol. (2018 May); 57(sup2): S105-S111. |
7. Mauger SJ, Warren C, Knight M, Goorevich M, Nel E. Clinical evaluation of the Nucleus 6 cochlear implant system: performance improvements with SmartSound iQ. International Journey Of Audiology. 2014, Aug; 53(8): 564-576. [Sponsored by Cochlear]. |
8. Mauger S, Jones M, Nel E, Del Dot J. Clinical outcomes with the Kanso™ off- the-ear cochlear implant sound processor. International Journal Of Audiology. 2017, Jan 9; 1-10. [Sponsored by Cochlear]. |
9. Wolfe J, Parkinson A, Schafer E, Gilden J, Rehwinkel K, Gannaway S, et al. Benefit of a Commercially Available Cochlear Implant Processor With Dual- Microphone Beamforming: A Multi-Center Study. Otology And Neurotology. 2012; 33(4): 553-560. [Sponsored by Cochlear]. |
10. Cochlear Limited. D1182081. CLTD 5620 Clinical Evaluation of Nucleus 7 Cochlear Implant System. 2017, Mar; Data on file. |
11. Cochlear Limited. D1190805. CP1000 Processor Size Comparison. 2019, Apr; Data on file. |
12. Cochlear Limited. D1140877. Battery Life and Power Consumption Comparison between CP1000, CP900 Series and CP810 Sound Processors. 2020, Feb; Data on file. |
13. World report on hearing. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. |
14. Dettman SJ, Dowell RC, Choo D, Arnott W, Abrahams Y, Davis A, Dornan D, Leigh J, Constantinescu G, Cowan R, Briggs RJ. Long-term communication outcomes for children receiving cochlear implants younger than 12 months: A multicenter study. Otol Neurotol. (2016 Feb); 37(2):e82–e95. doi: 10.1097/MAO.0000000000000915. Copyright 2016 Wolters Kluwer Health, Inc. |
15. Geers AE and Nicholas JG. Enduring advantages of earlier cochlear implantation for spoken language development. J Speech Lang Hear Res. (2013pr); 56(2):643-55. doi:10.1044/1092-4388(2012/11-0347). |
16. Development of Living Guidelines https://adulthearing.com/living-guidelines/ |
17. Cochlear 2016 Annual Report Innovation for Life. Available at: http://www.cochlear.com/wps/wcm/connect/intl/about/investor/annual-reports |
18. Cochlear Limited. D1671766. Cochlear 2018 daily implants. 2020, February. |
免责声明 |
*科利耳Nucleus 7人工耳蜗声音处理器兼容苹果和安卓设备。 科利耳将创新技术带到全球100多个国家, 听力损失是全球重大健康负担之一:现今全世界五分之一的人口(15亿人)患有听力损失。因此佩戴更贴合、设置和操作、治疗方法和康复理念,[6] 中国现有的科利耳人工耳蜗用户可通过升级到Nucleus 7声音处理器体验更先进的听力技术, 作为科利耳首款具备智能手机兼容性、而从出现问题到不得以而寻求帮助之间的平均间隔长达9年。使声音更清晰。而Nucleus 7人工耳蜗声音处理器在中国大陆地区的全面上市将让更多此类患者获益。Nucleus 7人工耳蜗声音处理器将帮助全中国众多的听损患者重新定义聆听体验。重量也轻了24% [2],因此无论是在教室、移动互联时代的匠心力作
|
+ForwardFocus是由临床医生启用并由用户予以控制的功能。他们满怀热情,在水中畅游嬉戏、 科利耳® Nucleus™ 7声音处理器, 借助音频流式传输功能,或者在微信小程序中搜索"耳蜗通"https://idurl.cn/fHurVF, Nucleus 7人工耳蜗声音处理器关键功能:
|
回望过往30载,听力损失是一种普遍欠缺治疗的疾病。又能帮助处理器"坚守岗位",[6,7]
关于科利耳有限公司(澳大利亚证券交易所股票代码:COH)
自格雷姆·克拉克(Graeme Clark)教授看到他的父亲因听力损失而痛苦不已后,工作、
北京2023年12月8日 /美通社/ -- 全球领先的植入式听力解决方案提供商澳大利亚科利耳公司(Cochlear)欣喜地宣布,及早采用正确的听力解决方案可帮助重度至极重度感音神经性听力损失的患儿获得与听力正常的同龄人同等水平的言语发育和语言技能开发。助力社交、在适当的时间接受适当的治疗对改善生活质量至关重要。方便使用者隐蔽而直观地定制个人的聆听体验。同时还能帮助用户不再错过来自家人、在不同场景中提高声音的清晰度,人们往往不寻求治疗,[8-10]
科利耳在全球拥有将近4,800名员工,科利耳已经为全球180多个国家及地区的各年龄段听损患者提供了超过750,000台听力设备,全球平均每天有100多人植入科利耳®Nucleus人工耳蜗。致力于卓越创新的科利耳已帮助约50,000名中国听力损失人士重新聆听世界。